![](https://www.ibj.com/wp-content/uploads/2019/01/otb-lilly-2col-300x199.jpg)
Eli Lilly to acquire Massachusetts-based biotech for $309M
The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.